Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roni Bitterman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2025
Serum Ammonia Screening and Donor Mollicute Detection for Hyperammonemia Syndrome Post-Lung Transplant: A Prospective Observational StudyLaura N Walti, Chun Fai Ng, Simran Kaur, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 18, 2025
Mycobacterium abscessus Complex Infections Among Lung Transplant Recipients: A Multicenter Retrospective Cohort Study in CanadaRoni Bitterman, Hafid Soualhine, Pierre-Marie Akochy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomesAmir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Elena Carrara, Pilar Retamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistanceSammy Frenk, Elizabeth Temkin, Mor N Lurie-Weinberger, et al.
Gerontology|October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2025
Serum Ammonia Screening and Donor Mollicute Detection for Hyperammonemia Syndrome Post-Lung Transplant: A Prospective Observational StudyLaura N Walti, Chun Fai Ng, Simran Kaur, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 18, 2025
Mycobacterium abscessus Complex Infections Among Lung Transplant Recipients: A Multicenter Retrospective Cohort Study in CanadaRoni Bitterman, Hafid Soualhine, Pierre-Marie Akochy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomesAmir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Elena Carrara, Pilar Retamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistanceSammy Frenk, Elizabeth Temkin, Mor N Lurie-Weinberger, et al.
Gerontology|October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Pageof 4